Literature DB >> 21946107

Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism.

Evandro M Neto-Neves1, Carlos A Dias-Junior, Juliana A Uzuelli, Romaiana P Pereira, Fernando Spiller, Paula G Czaikoski, Jose E Tanus-Santos.   

Abstract

We investigated whether atorvastatin has beneficial hemodynamic effects during acute pulmonary thromboembolism (APT) and whether sildenafil improves these effects. We studied the involvement of oxidative stress, matrix metalloproteinases (MMPs), and neutrophil activation. APT was induced with autologous blood clots (500 mg/kg) in anesthetized male lambs pretreated with atorvastatin (10 mg/kg/day, subcutaneously; 1 week) or vehicle (dimethyl sulfoxide 10% subcutaneously). Sildenafil (0.7 mg/kg intravenously) or saline infusions were performed 60 min after APT induction. Non-embolized control animals received saline. APT significantly increased pulmonary vascular resistance index (PVRI) and mean pulmonary artery pressure (MPAP) by approximately 310% and 258% respectively. While atorvastatin pretreatment attenuated these increases (~150% and 153%, respectively; P < 0.05), its combination with sildenafil was associated with lower increases in PVRI and MPAP (~32% and 36%, respectively). Gelatin zymography showed increased MMP-9 and MMP-2 levels in the bronchoalveolar lavage, and increased MMP-9 levels in plasma from embolized animals. Atorvastatin pretreatment attenuated bronchoalveolar lavage MMP-2 increases. The combination of drugs blunted the MMPs increases in bronchoalveolar lavage and plasma (P < 0.05). Neutrophils accumulated in bronchoalveolar lavage after APT, and atorvastatin pretreatment combined with sildenafil (but not atorvastatin alone) attenuated this effect (P < 0.05). APT increased lung lipid peroxidation and total protein concentrations in bronchoalveolar lavage, thus indicating oxidative stress and alveolar-capillary barrier damage, respectively. Both increases were attenuated by atorvastatin pretreatment alone or combined with sildenafil (P < 0.05). We conclude that pretreatment with atorvastatin protects against the pulmonary hypertension associated with APT and that sildenafil improves this response. These findings may reflect antioxidant effects and inhibited neutrophils/MMPs activation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946107     DOI: 10.1016/j.ejphar.2011.09.018

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Association Between Inflammatory Mediators and Pulmonary Blood Flow in a Rabbit Model of Acute Pulmonary Embolism Combined With Shock.

Authors:  Yuting Wang; Delong Yu; Yijun Yu; Xiaoyan Liu; Liqun Hu; Ye Gu
Journal:  Front Physiol       Date:  2020-09-02       Impact factor: 4.566

2.  Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms.

Authors:  Cesar A Meschiari; Tatiane Izidoro-Toledo; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2013-03-03       Impact factor: 3.396

3.  Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction.

Authors:  Jaqueline J Muniz; Riccardo Lacchini; Jonas T C Sertório; Alceu A Jordão; Yuri T D A Nobre; Silvio Tucci; Antônio C P Martins; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05-19       Impact factor: 3.000

4.  Importance of oxidative stress in the evaluation of acute pulmonary embolism severity.

Authors:  Gülseren Sagcan; Dildar Konukoglu; Hafize Uzun; Orhan Arseven; Gulfer Okumus; Caglar Cuhadaroglu
Journal:  BMC Pulm Med       Date:  2022-10-17       Impact factor: 3.320

5.  Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.

Authors:  Danielle A Guimarães; Elen Rizzi; Carla S Ceron; Alisson Martins-Oliveira; Raquel F Gerlach; Sruti Shiva; Jose E Tanus-Santos
Journal:  Redox Biol       Date:  2015-08-31       Impact factor: 11.799

6.  Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.

Authors:  Evandro M Neto-Neves; Ozelia Sousa-Santos; Karina C Ferraz; Elen Rizzi; Carla S Ceron; Minna M D Romano; Luis G Gali; Benedito C Maciel; Richard Schulz; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  J Cell Mol Med       Date:  2013-11-06       Impact factor: 5.310

7.  Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension.

Authors:  Danielle A Guimarães; Elen Rizzi; Carla S Ceron; Lucas C Pinheiro; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Redox Biol       Date:  2013-11-17       Impact factor: 11.799

8.  Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension.

Authors:  Ananda T Dias; Amanda S Cintra; Jéssica C Frossard; Zaira Palomino; Dulce E Casarini; Isabele B S Gomes; Camille M Balarini; Agata L Gava; Bianca P Campagnaro; Thiago M C Pereira; Silvana S Meyrelles; Elisardo C Vasquez
Journal:  J Transl Med       Date:  2014-09-16       Impact factor: 5.531

9.  A porcine in-vivo model of acute pulmonary embolism.

Authors:  Jacob Schultz; Asger Andersen; Inger Lise Gade; Steffen Ringgaard; Benedict Kjaergaard; Jens Erik Nielsen-Kudsk
Journal:  Pulm Circ       Date:  2017-10-03       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.